|
[1]
|
Singal, A.G., Zhang, E., Narasimman, M., et al. (2022) HCC Surveillance Improves Early Detection, Curative Treatment Receipt, and Survival in Patients with Cirrhosis: A Meta-Analysis. Journal of Hepatology, 77, 128-139. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Wang, W. and Wei, C. (2020) Advances in the Early Diagnosis of Hepatocellular Carcinoma. Genes & Diseases, 7, 308-319. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Tzartzeva, K., Obi, J., Rich, N.E., et al. (2018) Surveillance Im-aging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis: A Me-ta-Analysis. Gastroenterology, 154, 1706-1718.E1. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Mandel, P. and Metais, P. (1948) Les acides nucléiques du plas-ma sanguin chez l’homme. Comptes rendus des séances de la société de biologie et de ses filiales, 142, 241-243.
|
|
[5]
|
Van Helden, E.J., Angus, L., et al. (2019) RAS and BRAF Mutations in Cell-Free DNA Are Predictive for Outcome of Cetuximab Monotherapy in Patients with Tissue-Tested RAS Wild-Type Advanced Colorectal Cancer. Molecular Oncology, 13, 2361-2374. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Lo, Y.M.D., Han, D.S.C., Jiang, P., et al. (2021) Epigenetics, Fragmentomics, and Topology of Cell-Free DNA in Liquid Biopsies. Science (New York, N.Y.), 372, eaaw3616. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Piciocchi, M., Cardin, R., Vitale, A., et al. (2013) Circulating Free DNA in the Progression of Liver Damage to Hepatocellular Carcinoma. Hepatology Interna-tional, 7, 1050-1057. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Guarino, M. (2007) Epithelial-Mesenchymal Transition and Tumour Invasion. The International Journal of Biochemistry & Cell Biology, 39, 2153-2160. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Chen, V.L., Xu, D., Wicha, M.S., et al. (2020) Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic Review. Clinical Gastroenterology and Hepatology, 18, 2879-2902E9. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
El-Mazny, A., Sayed, M. and Sharaf, S. (2014) Human Telomerase Reverse Transcriptase Messenger RNA (TERT MRNA) as a Tumour Marker for Early Detection of Hepatocellular Car-cinoma. Arab Journal of Gastroenterology: The Official Publication of the Pan-Arab Association of Gastroenterology, 15, 68-71. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Deng, Z., Wu, S., Wang, Y., et al. (2022) Circulating Tumor Cell Isolation for Cancer Diagnosis and Prognosis. EBioMedicine, 83, Article ID: 104237. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Chen, L., Guo, P., He, Y., et al. (2018) HCC-Derived Exosomes Elicit HCC Progression and Recurrence by Epithelial-Mesenchymal Transition through MAPK/ERK Signalling Pathway. Cell Death & Disease, 9, Article No. 513. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Doldán, X., Fagúndez, P., Cayota, A., et al. (2016) Electrochemi-cal Sandwich Immunosensor for Determination of Exosomes Based on Surface Marker-Mediated Signal Amplification. Analytical Chemistry, 88, 10466-10473. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Chen, L., Abou-Alfa, G.K., Zheng, B., et al. (2021) Ge-nome-Scale Profiling of Circulating Cell-Free DNA Signatures for Early Detection of Hepatocellular Carcinoma in Cir-rhotic Patients. Cell Research, 31, 589-592. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Cohen, J.D., Li, L., Wang, Y., et al. (2018) Detection and Local-ization of Surgically Resectable Cancers with a Multi-Analyte Blood Test. Science (New York, N.Y.), 359, 926-930.
|
|
[16]
|
Foda, Z.H., Annapragada, A.V., Boyapati, K., et al. (2023) Detecting Liver Cancer Using Cell-Free DNA Fragmentomes. Cancer Discovery, 13, 616-631. [Google Scholar] [CrossRef]
|
|
[17]
|
Cho, H.J., Eun, J.W., Baek, G.O., et al. (2020) Serum Exosomal MicroRNA, MiR-10b-5p, as a Potential Diagnostic Biomarker for Early-Stage Hepatocellular Carcinoma. Journal of Clinical Medicine, 9, Article No. 281. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Li, W., Ding, X., Wang, S., et al. (2020) Downregulation of Serum Exo-somal MiR-320d Predicts Poor Prognosis in Hepatocellular Carcinoma. Journal of Clinical Laboratory Analysis, 34, E23239. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Cheng, Y., Luo, L., Zhang, J., et al. (2019) Diagnostic Value of Different Phenotype Circulating Tumor Cells in Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract, 23, 2354-2361. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Park, S., Lee, E.J., Rim, C.H., et al. (2018) Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma. Yonsei Medical Journal, 59, 470-479. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Watanabe, T., Suzuki, Y., Kuroda, H., et al. (2023) Circulating Cell-Free DNA as a Biomarker for Prognosis and Response to Systemic Therapy in Patients with Unresectable Hepato-cellular Carcinoma. Oncology, 101, 714-722. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Li, F., Qiao, C.Y., Gao, S., et al. (2018) Circulating Cell-Free DNA of Methylated Insulin-Like Growth Factor-Binding Protein 7 Predicts a Poor Prognosis in Hepatitis B Virus-Associated Hepatocellular Carcinoma after Hepatectomy. Free Radical Research, 52, 455-464. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Wang, L., Li, Y., Xu, J., et al. (2018) Quantified Postsurgi-cal Small Cell Size CTCs and EpCAM(+) Circulating Tumor Stem Cells with Cytogenetic Abnormalities in Hepatocellu-lar Carcinoma Patients Determine Cancer Relapse. Cancer Letters, 412, 99-107. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Cai, Z., Chen, G., Zeng, Y., et al. (2019) Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma. Clinical Cancer Research, 25, 5284- 5294. [Google Scholar] [CrossRef]
|
|
[25]
|
Wang, Z., Luo, L., Cheng, Y., et al. (2018) Correlation be-tween Postoperative Early Recurrence of Hepatocellular Carcinoma and Mesenchymal Circulating Tumor Cells in Pe-ripheral Blood. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract, 22, 633-639. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Feng, H., Li, B., Li, Z., et al. (2021) PIVKA-II Serves as a Poten-tial Biomarker That Complements AFP for the Diagnosis of Hepatocellular Carcinoma. BMC Cancer, 21, Article No. 401. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Shaik, M.R., Sagar, P.R., Shaik, N.A., et al. (2023) Liquid Bi-opsy in Hepatocellular Carcinoma: The Significance of Circulating Tumor Cells in Diagnosis, Prognosis, and Treatment Monitoring. International Journal of Molecular Sciences, 24, Article No. 10644. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Ma, S., Zhou, M., Xu, Y., et al. (2023) Clinical Application and De-tection Techniques of Liquid Biopsy in Gastric Cancer. Molecular Cancer, 22, Article No. 7. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Zhang, Z., Wu, H., Chong, W., et al. (2022) Liquid Biopsy in Gastric Cancer: Predictive and Prognostic Biomarkers. Cell Death & Disease, 13, Article No. 903. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Trevisan França De Lima, L., Broszczak, D., Zhang, X., et al. (2020) The Use of Minimally Invasive Biomarkers for the Diagnosis and Prognosis of Hepatocellular Carcinoma. Bio-chimica et Biophysica Acta. Reviews on Cancer, 1874, Article ID: 188451. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Nikanjam, M., Kato, S. and Kurzrock, R. (2022) Liquid Biopsy: Current Technology and Clinical Applications. Journal of Hematology & Oncology, 15, Article No. 131. [Google Scholar] [CrossRef] [PubMed]
|